Related Experiment Videos
Summary
Human lymphocytes interact with target cells in varied ways, sometimes using fibroblasts as feeder cells. Tumor-specific lymphocytes from patients and healthy donors can kill tumor cells, with serum factors modulating these cytotoxic effects.
Area of Science:
- Immunology
- Cell Biology
- Oncology
Background:
- Lymphocyte interactions with target cells exhibit significant variability.
- Fibroblasts can act as feeder cells for lymphocytes, supporting their division and leading to fibroblast death without direct immunological involvement.
- Tumor-infiltrating lymphocytes, including T cells and NK cells, possess cytotoxic potential against tumor cells.
Purpose of the Study:
- To investigate the complex interactions between human lymphocytes and target cells, including non-immune feeder cell roles.
- To analyze the cytotoxic activity of lymphocytes from tumor-bearing patients and healthy donors against tumor cells.
- To examine the influence of serum factors on lymphocyte-mediated cytotoxicity.
Main Methods:
- Observation of lymphocyte-fibroblast interactions, including material transfer and lymphocyte division within fibroblasts.
- Assessment of lymphocyte-mediated tumor cell lysis using autologous and allogeneic tumor cells.
- Evaluation of serum factor effects on both patient and healthy donor lymphocyte cytotoxicity.
Main Results:
- Lymphocytes can internalize material from fibroblasts via cytoplasmic bridges, leading to lymphocyte proliferation and fibroblast demise.
- Both T and NK lymphocytes from tumor patients demonstrate cytotoxicity against autologous and/or allogeneic tumor cells.
- Serum factors can inhibit or enhance lymphocyte cytotoxicity, with differential effects observed between patient and healthy donor lymphocytes.
- Cytotoxicity of healthy donor lymphocytes against tumor cells is often resistant to blocking by serum factors that inhibit patient lymphocyte activity.
Conclusions:
- Lymphocyte-target cell interactions are multifaceted, involving non-immune feeder cell mechanisms and direct cytotoxicity.
- Tumor-associated lymphocytes exhibit cytotoxic potential, which can be modulated by serum factors.
- Healthy donor lymphocytes may possess distinct mechanisms or resistance profiles to serum-mediated inhibition of tumor cell killing, suggesting potential therapeutic avenues.